fluarix Report issue

Vaccine Experimental
AACT

Active Ingredient History

NOW
  • Now
Influenza vaccines, colloquially known as flu shots, are vaccines that protect against infection by influenza viruses. New versions of the vaccines are developed twice a year, as the influenza virus rapidly changes. While their effectiveness varies from year to year, most provide modest to high protection against influenza. Vaccination against influenza began in the 1930s, with large-scale availability in the United States beginning in 1945.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data

Alternative names

fluarix

Organizations (38)

Research & Development (38)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (8)

Approved Indications (1)


 

Influenza Vaccines

Experimental Indications - Clinical Trial Phases 1-4 (8)


 

Geriatrics (Phase 4)

Healthy Volunteers (Phase 2)

Heart Failure (Phase 4)

Influenza, Human (Phase 4)

Influenza Vaccines (Phase 2)

Lymphoma (Phase 4)

Meningococcal Infections (Phase 3)

SARS-CoV-2 (Phase 1/Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 61
  • # of Trial Organizations: 38

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue